GSZPX | VEXRX | GSZPX / VEXRX | |
Total Expense Ratio | 0.84 | 0.34 | 247% |
Annual Report Gross Expense Ratio | 1.06 | 0.34 | 312% |
Fund Existence | 7 years | 23 years | - |
Gain YTD | -14.541 | -13.374 | 109% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 50000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 116M | 19.8B | 1% |
Annual Yield % from dividends | 0.90 | 0.56 | 161% |
Returns for 1 year | 1.85 | -11.24 | -16% |
Returns for 3 years | 14.68 | -8.96 | -164% |
Returns for 5 years | -30.58 | 17.63 | -173% |
Returns for 10 years | N/A | 0.85 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XBI | 80.89 | 1.79 | +2.26% |
SPDR® S&P Biotech ETF | |||
FEP | 42.41 | 0.74 | +1.78% |
First Trust Europe AlphaDEX® ETF | |||
SBIO | 28.51 | 0.49 | +1.75% |
ALPS Medical Breakthroughs ETF | |||
BCDF | 28.98 | 0.44 | +1.54% |
Horizon Kinetics Blockchain Dev ETF | |||
CHI | 9.92 | 0.14 | +1.43% |
Calamos Convertible Opportunities and Income Fund |